RNAC
Price
$11.04
Change
+$1.69 (+18.09%)
Updated
Jun 6 closing price
Capitalization
243.45M
SNGX
Price
$1.93
Change
+$0.09 (+4.89%)
Updated
Jun 6 closing price
Capitalization
6.01M
Interact to see
Advertisement

RNAC vs SNGX

Header iconRNAC vs SNGX Comparison
Open Charts RNAC vs SNGXBanner chart's image
Cartesian Therapeutics
Price$11.04
Change+$1.69 (+18.09%)
Volume$100.18K
Capitalization243.45M
Soligenix
Price$1.93
Change+$0.09 (+4.89%)
Volume$32.69K
Capitalization6.01M
RNAC vs SNGX Comparison Chart
Loading...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RNAC vs. SNGX commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNAC is a Buy and SNGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (RNAC: $9.09 vs. SNGX: $1.93)
Brand notoriety: RNAC and SNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RNAC: 89% vs. SNGX: 12%
Market capitalization -- RNAC: $243.45M vs. SNGX: $6.01M
RNAC [@Biotechnology] is valued at $243.45M. SNGX’s [@Biotechnology] market capitalization is $6.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RNAC’s FA Score shows that 0 FA rating(s) are green whileSNGX’s FA Score has 1 green FA rating(s).

  • RNAC’s FA Score: 0 green, 5 red.
  • SNGX’s FA Score: 1 green, 4 red.
According to our system of comparison, SNGX is a better buy in the long-term than RNAC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNAC’s TA Score shows that 5 TA indicator(s) are bullish while SNGX’s TA Score has 4 bullish TA indicator(s).

  • RNAC’s TA Score: 5 bullish, 3 bearish.
  • SNGX’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, both RNAC and SNGX are a good buy in the short-term.

Price Growth

RNAC (@Biotechnology) experienced а -2.05% price change this week, while SNGX (@Biotechnology) price change was +2.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNAC($243M) has a higher market cap than SNGX($6.01M). SNGX YTD gains are higher at: -28.386 vs. RNAC (-49.246). SNGX has higher annual earnings (EBITDA): -8.06M vs. RNAC (-75.99M). RNAC has more cash in the bank: 213M vs. SNGX (9.84M). SNGX has less debt than RNAC: SNGX (2.2M) vs RNAC (14M). RNAC has higher revenues than SNGX: RNAC (38.9M) vs SNGX (0).
RNACSNGXRNAC / SNGX
Capitalization243M6.01M4,046%
EBITDA-75.99M-8.06M942%
Gain YTD-49.246-28.386173%
P/E Ratio1.76N/A-
Revenue38.9M0-
Total Cash213M9.84M2,165%
Total Debt14M2.2M635%
FUNDAMENTALS RATINGS
RNAC vs SNGX: Fundamental Ratings
RNAC
SNGX
OUTLOOK RATING
1..100
562
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
9589
P/E GROWTH RATING
1..100
62100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNGX's Valuation (29) in the Biotechnology industry is significantly better than the same rating for RNAC (99). This means that SNGX’s stock grew significantly faster than RNAC’s over the last 12 months.

SNGX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RNAC (100). This means that SNGX’s stock grew similarly to RNAC’s over the last 12 months.

SNGX's SMR Rating (99) in the Biotechnology industry is in the same range as RNAC (100). This means that SNGX’s stock grew similarly to RNAC’s over the last 12 months.

SNGX's Price Growth Rating (89) in the Biotechnology industry is in the same range as RNAC (95). This means that SNGX’s stock grew similarly to RNAC’s over the last 12 months.

RNAC's P/E Growth Rating (62) in the Biotechnology industry is somewhat better than the same rating for SNGX (100). This means that RNAC’s stock grew somewhat faster than SNGX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RNACSNGX
RSI
ODDS (%)
Bullish Trend 11 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 11 days ago
76%
Momentum
ODDS (%)
Bearish Trend 11 days ago
87%
Bullish Trend 11 days ago
77%
MACD
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 11 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
89%
Advances
ODDS (%)
Bullish Trend about 1 month ago
82%
Bullish Trend 11 days ago
77%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 11 days ago
71%
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

SNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNGX has been closely correlated with ALLR. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNGX jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNGX
1D Price
Change %
SNGX100%
+1.05%
ALLR - SNGX
85%
Closely correlated
-2.33%
WINT - SNGX
82%
Closely correlated
+5.12%
RNAC - SNGX
81%
Closely correlated
+3.65%
NRXP - SNGX
81%
Closely correlated
+0.39%
CDTX - SNGX
81%
Closely correlated
-5.46%
More